Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

Go back to Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
(NASDAQ: COCH) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High
Open $0.66    52 Week Low
Day High $0.66    P/E N/A 
Day Low $0.66    EPS
Volume 1,754